UPDATE: Danaher Q1 Revenues Rise 5 Percent; CEO Culp Retiring Next Year | GenomeWeb

The story has been updated to include comments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher said after the close of the market on Wednesday that total revenues for the first quarter increased 5 percent year over year as revenues from its Life Sciences and Diagnostics segment rose nearly 6 percent.

The company also announced that its President and CEO Lawrence Culp will retire on March 1, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.